When will the FDA approve Compass Pathways' COMP360 Psilocybin?
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Begins in 362 days · Jun 30, 12:00am EDT
Chance
Before Mar 1, 2027
49%
▲ 4
Before Mar 1, 2027
49%
▲ 4
Before July 2027
76%
Before July 2027
76%
Before October 2027
77%
Before October 2027
77%
2 more
Market Rules
Before Jan 1, 2027
Resolves Yes if the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027.Outcome verified from U.S. Food and Drug Administration., FDA, and Compass Pathways.
Timeline and payout
Market openMay 15, 2026 · 10:30pm EDT
Market closesAfter the outcome occurs
Projected payout30 minutes after closing
SeriesKXFDAAPPROVALDATECMPS
EventKXFDAAPPROVALDATECMPS-360
MarketKXFDAAPPROVALDATECMPS-360-27JAN01
Insider trading is prohibited
The following are prohibited from trading this contract:
- Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
- Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.
Before Jan 1, 2027
Odds
0% chanceMax payout